This site is intended for healthcare professionals
News

Ironwood to discontinue IW-3718 development program of IW-3718 in refractory gastroesophageal reflux disease following results from planned efficacy assessment.

Read time: 1 mins
Last updated:30th Sep 2020
Published:30th Sep 2020
Condition: GERD
Type: drug
Register free for full access to medthority.com